Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-009101
Filing Date
2025-02-04
Accepted
2025-02-04 16:06:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8821
2 EXHIBIT I tm255438d1_ex-1.htm EX-99.1 4279
  Complete submission text file 0001104659-25-009101.txt   15142
Mailing Address 399 PARK AVENUE NEW YORK NY 10022
Business Address 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
MILLENNIUM MANAGEMENT LLC (Filed by) CIK: 0001273087 (see all company filings)

EIN.: 133804139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121 (858) 263-4333
Zentalis Pharmaceuticals, Inc. (Subject) CIK: 0001725160 (see all company filings)

EIN.: 823607803 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91478 | Film No.: 25588150
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)